dantetzl – Hibiscus BioVentures

All NexImmune

NexImmune Announces Pricing of Upsized Initial Public Offering

All NexImmune

Immunotherapy Veteran Robert Knight, MD, Joins NexImmune as Chief Medical Office

All

Bayer and Northpond Ventures Lead USD 55 million Series A Financing Round for Triumvira Immunologics

All NexImmune

NexImmune to Present at the Jefferies Virtual Healthcare Conference

All Cereno Scientific

The Board and Chief Executive Officer of Cereno Scientific AB here with present the Interim Report for the first quarter 2020

All Cereno Scientific

Cereno Scientific announces US subsidiary in Cambridge, Boston, MA

All Cereno Scientific

Cereno Scientific adds a clinical expert to its ODD track

All Cereno Scientific

FDA grants Cereno Scientific’s lead candidate Orphan Drug Designation

All NexImmune

NexImmune Expands Executive Team with Appointments of Chief Medical Officer and Chief Financial Officer

All Asclepix Therapeutics

AsclepiX Therapeutics, Inc. Expands Leadership Team with Appointment of Industry Leader Theresa Heah, MD, MBA as Chief Medical Officer

© 2021 Hibiscus BioVentures.